Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amyris Inc (AMRS) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 196,170
  • Shares Outstanding, K 235,020
  • Annual Sales, $ 34,150 K
  • Annual Income, $ -217,950 K
  • 36-Month Beta 0.37
  • Price/Sales 3.58
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.59
  • Most Recent Earnings -0.07 on 11/02/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.67 +2.99%
on 12/22/16
0.83 -16.87%
on 01/09/17
+0.02 (+2.99%)
since 12/16/16
3-Month
0.67 +2.99%
on 12/22/16
1.21 -42.98%
on 10/19/16
-0.20 (-22.47%)
since 10/17/16
52-Week
0.31 +122.58%
on 06/28/16
1.63 -57.67%
on 02/19/16
-0.62 (-47.33%)
since 01/15/16

Most Recent Stories

More News
Specialty Chemicals Stocks Under Review -- Amyris, LyondellBasell Industries, Platform Specialty Products, and Olin

Stock-Callers.com puts focus on the Specialty Chemicals industry to see how some equities have fared over the last few trading sessions. Companies in today's lineup are: Amyris Inc. (NASDAQ: AMRS), LyondellBasell...

Is the Options Market Predicting a Spike in Amyris (AMRS) Stock?

Options traders are pricing in a big move for Amyris (AMRS) shares as it has huge implied volatility.

Chevron Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology

Chevron Products Company, a division of Chevron U.S.A. Inc., and Novvi LLC today announced that Chevron has made an equity investment into Novvi LLC (a joint venture of Amyris, Inc. (Nasdaq:AMRS), Cosan...

Amyris & NIKKOL GROUP Create Leading Cosmetics Ingredient Joint Venture

Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced it has signed a definitive agreement to establish a cosmetic ingredients joint venture with NIKKOL GROUP ("NIKKOL"), a leading...

Amyris Partners with Queensland to Create the leading Industrial Biotechnology Hub in Southeast Asia

Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and the Government of Queensland, Australia today announced a partnership to create a southeast hub of sustainable ingredients production...

Basic Materials Stocks Under Review -- ArcelorMittal, United States Steel, Amyris, and LyondellBasell Industries

Stock-Callers.com revisits the Basic Materials sector with focus on these four equities: ArcelorMittal (NYSE: MT), United States Steel Corp. (NYSE: X), Amyris Inc. (NASDAQ: AMRS), and LyondellBasell Industries...

Weakness Seen in Amyris (AMRS) Estimates: Should You Stay Away?

Amyris (AMRS) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.

Amyris to Present at Four Upcoming Investor Conferences in December

Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in December 2016.

Arzeda Scales High-throughput, Automated Molecule Development Pipeline

Creates industrial molecules that can be produced via fermentation to meet demand in commercial markets

Arzeda Scales High-throughput, Automated Molecule Development Pipeline

Creates industrial molecules that can be produced via fermentation to meet demand in commercial markets

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Support & Resistance

2nd Resistance Point 0.75
1st Resistance Point 0.72
Last Price 0.69
1st Support Level 0.67
2nd Support Level 0.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.